Long-acting insulin analogues (KTT12) by all CCGs

Why it matters: NICE recommend that for patients with type 2 diabetes requiring insulin, 'neutral protamine Hagedorn' (NPH) insulin is the preferred starting therapy with insulin, and that the more expensive long-acting insulin analogues (detemir and insulin glargine) can be considered as an alternative in certain circumstances.

Description: Number of prescription items for long-acting human analogue insulins as a percentage of the total number of prescription items for all long-acting and intermediate acting insulins excluding biphasic insulins.


Tagged as: Standard, Cost Saving, Diabetes, NICE (or browse all measures)

CCGs are ordered by mean percentile over the past six months. Each chart shows the results for the individual CCG, plus deciles across all CCGs in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.